The structural basis of airways hyperresponsiveness in asthma.
Stănescu
Dan C
DC
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000420:Albuterol / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000473:pathology* / Q000503:physiopathology*; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology; D016085:Bronchoconstrictor Agents / Q000494:pharmacology; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000294:innervation / Q000473:pathology* / Q000503:physiopathology*; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D008875:Middle Aged; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation / Q000473:pathology / Q000503:physiopathology; D012115:Residual Volume / Q000187:drug effects / Q000502:physiology; D012132:Respiratory Muscles / Q000294:innervation / Q000473:pathology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed; D014109:Total Lung Capacity / Q000187:drug effects / Q000502:physiology; D014797:Vital Capacity / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists; D016085:Bronchoconstrictor Agents; D001993:Bronchodilator Agents; D016210:Methacholine Chloride; D000420:Albuterol